An Extraordinary New Treatment Option for Ovarian ...
An Extraordinary New Treatment Option for Ovarian Cancer – PARP Inhibitors
Some types of ovarian cancer come about through inherited genetic mutations. “Some of these cancers, around 20% of them, have a hereditary component” says Dr. Jose Alejandro Rauh-Hain from the MD Anderson Cancer Center in Texas. This commonly comes in the form of a BRCA mutation, the same genetic mutation that is a risk factor for breast cancer. If an ovarian cancer is caused by a BRCA mutation, then a PARP inhibitor could be an effective treatment. “What we have seen,” says Dr. Rauh-Hain, “is that if patients have those kind of mutations….if they receive those medications the chances of the cancer coming back are much lower, and the patients that have received those medications actually live longer.”
Learn more about SurvivorNet's rigorous medical review process.
Some types of ovarian cancer come about through inherited genetic mutations. “Some of these cancers, around 20% of them, have a hereditary component” says Dr. Jose Alejandro Rauh-Hain from the MD Anderson Cancer Center in Texas. This commonly comes in the form of a BRCA mutation, the same genetic mutation that is a risk factor for breast cancer. If an ovarian cancer is caused by a BRCA mutation, then a PARP inhibitor could be an effective treatment. “What we have seen,” says Dr. Rauh-Hain, “is that if patients have those kind of mutations….if they receive those medications the chances of the cancer coming back are much lower, and the patients that have received those medications actually live longer.”
Learn more about SurvivorNet's rigorous medical review process.